# CI:Mor interactions in the lysogeny switches of Lactococcus lactis TP901-1 and Staphylococcus aureus φ13 bacteriophages

**Authors:** Anders K. Varming, Zhiyu Huang, Ghofran M. Hamad, Kim K. Rasmussen, Hanne Ingmer, Mogens Kilstrup, Leila Lo Leggio

PMC · DOI: 10.20517/mrr.2023.50 · Microbiome Research Reports · 2024-01-19

## TL;DR

This study explores how two bacteriophages regulate whether they lyse or infect bacteria by examining the interactions between proteins CI and Mor.

## Contribution

The study experimentally confirms and structurally models the direct interaction between CI and Mor in the φ13 bacteriophage for the first time.

## Key findings

- The CI interface in TP901-1 undergoes structural changes when binding to Mor.
- Direct interaction between CI and Mor in φ13 was experimentally confirmed and computationally modeled.
- Residue Glu69 in CI interacts with Mor through its aliphatic chain after conformational changes.

## Abstract

Aim: To structurally characterize in detail the interactions between the phage repressor (CI) and the antirepressor (Mor) in the lysis-lysogeny switches of two Gram-positive bacteriophages, the lactococcal TP901-1 and staphylococcal φ13.

Methods: We use crystallographic structure determination, computational structural modeling, and analysis, as well as biochemical methods, to elucidate similarities and differences in the CI:Mor interactions for the two genetic switches.

Results: By comparing a newly determined and other available crystal structures for the N-terminal domain of CI (CI-NTD), we show that the CI interface involved in Mor binding undergoes structural changes upon binding in TP901-1. Most importantly, we show experimentally for the first time the direct interaction between CI and Mor for φ13, and model computationally the interaction interface. The computational modeling supports similar side chain rearrangements in TP901-1 and φ13.

Conclusion: This study ascertains experimentally that, like in the TP901-1 lysogeny switch, staphylococcal φ13 CI and Mor interact with each other. The structural basis of the interaction of φ13 CI and Mor was computationally modeled and is similar to the interaction demonstrated experimentally between TP901-1 CI-NTD and Mor, likely involving similar rearrangement of residue side chains during the formation of the complex. The study identifies one CI residue, Glu69, which unusually interacts primarily through its aliphatic chain with an aromatic residue on Mor after changing its conformation compared to the un-complexed structure. This and other residues at the interface are suggested for investigation in future studies.

## Linked entities

- **Proteins:** NDUFB6 (NADH:ubiquinone oxidoreductase subunit B6), OPRM1 (opioid receptor mu 1)
- **Species:** Lactococcus lactis (taxon 1358), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** Cro [NCBI Gene 2703467], CI [NCBI Gene 3827059], RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}
- **Diseases:** Mor (MESH:C538399), MRSA (MESH:D013203), NTD (MESH:D009436), CI-NTD (OMIM:300855), OL (MESH:C564538), bacteremia (MESH:D016470)
- **Chemicals:** Ala (MESH:D000409), Tyr (MESH:D014443), His (MESH:D006639), ammonium sulfate (MESH:D000645), Imidazole (MESH:C029899), water (MESH:D014867), Phe (MESH:D010649), phosphoric acid (MESH:C030242), SDS (MESH:D012967), NaCl (MESH:D012965), nitrogen (MESH:D009584), PEG 4000 (MESH:C000595214), Hamad (-), Methicillin (MESH:D008712), glycerol (MESH:D005990), amines (MESH:D000588), trichloroacetic acid (MESH:D014238), kanamycin (MESH:D007612)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Lactococcus lactis (species) [taxon 1358], Escherichia coli BL21(DE3) (strain) [taxon 469008], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Phe75, Phe75Tyr, Phe75 to Ala, Tyr75, Phe75Ile, Phe75Val, Met73 to Ala
- **Cell lines:** TP901-1 — Homo sapiens (Human), Hunter syndrome, Finite cell line (CVCL_CX32), phi13 — Homo sapiens (Human), Pleural malignant mesothelioma, Cancer cell line (CVCL_V417)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11149083/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11149083/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11149083/full.md

---
Source: https://tomesphere.com/paper/PMC11149083